Our previous study also indicated that elevated TMEM229A suppressed NSCLC progression via inactivating ERK (extracellular signal–regulated kinase) pathway [14], but the function of TMEM229A mutants in LUAD is unknown. This evidence concerns the gene TMEM229A and non-small cell lung carcinoma.